NCT00385645View on ClinicalTrials.gov

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

PHASE4CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
HIV Infections
Interventions
DRUG

Combivir+Kaletra

DRUG

Combivir+Reyataz

Trial Locations (7)

43007

Hospital Joan XXIII, Tarragona

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08003

Hospital del Mar, Barcelona

08025

Hospital de Sant Pau, Barcelona

08035

Hospital Vall d'Hebron, Barcelona

08036

Hospital Clinic, Barcelona

08221

Mutua de Terrassa, Terrassa

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT00385645 - Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis | Biotech Hunter | Biotech Hunter